Public health
fromArs Technica
3 days agoFDA slows down on drug reviews, approvals amid Trump admin chaos
FDA drug approvals slowed, review delays and rejections increased, manufacturing inspection issues rose, and a government shutdown prevents accepting new drug submissions.